Evidence map›Paper›PMID 42216962›Full record

ArticleBiometrics2026

A three-groups non-local model for combining heterogeneous data sources to identify genes associated with Parkinson's disease.

Troy P Wixson, Benjamin A Shaby, Daisy L Philtron, Leandro A Lima, Stacia K Wyman, Julia A Kaye, Steven Finkbeiner

Abstract read
In one paragraph

Article in Biometrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Troy P WixsonDepartment of Statistics, Colorado State University, Fort Collins, CO 80523, United States.ORCID 0009-0007-8238-3154
Benjamin A ShabyDepartment of Statistics, Colorado State University, Fort Collins, CO 80523, United States.ORCID 0000-0002-8663-536X
Daisy L PhiltronDepartment of Applied Mathematics and Statistics, Colorado School of Mines, Golden, CO 80401, United States.
Leandro A LimaCenter for Systems and Therapeutics, Gladstone Institutes, San Francisco, CA 94158, United States.
Stacia K WymanInnovative Genomics Institute, University of California Berkeley, Berkeley, CA 94720, United States.
Julia A KayeCenter for Systems and Therapeutics, Gladstone Institutes, San Francisco, CA 94158, United States.
Steven FinkbeinerCenter for Systems and Therapeutics, Gladstone Institutes, San Francisco, CA 94158, United States.

Funding

Image Tools for Computational Cellular Barcoding and Automated AnnotationR01LM013617 · NLM · J. DAVID GLADSTONE INSTITUTES · PI FINKBEINER, STEVEN M · 2022 to 2025
$1.6M
Dissecting the Etiology of The Lewy Body DementiasR01NS124848 · NINDS · J. DAVID GLADSTONE INSTITUTES · PI STEVEN M FINKBEINER · 2025 to 2026
$1.6M
CIRM DISC0-16039Colorado State UniversityGSKNIH HHS R01 LM013617NIH HHS R01 NS124848NSF NSF-1761941/2309825Pfizer
6 · The paper itself

Abstract

We seek to identify genes involved in Parkinson's disease (PD) by combining information across different experiment types. Each experiment, taken individually, may contain too little information to distinguish some important genes from incidental ones. However, when experiments are combined using the proposed statistical framework, additional power emerges. The fundamental building block of the family of statistical models that we propose is a hierarchical three-groups mixture of distributions. Each gene is modeled probabilistically as belonging to either a null group that is unassociated with PD, a deleterious group, or a beneficial group. This three-groups formalism has two key features. By apportioning prior probability of group assignments with a Dirichlet distribution, the resultant posterior group probabilities automatically account for the multiplicity inherent in analyzing many genes simultaneously. By building models for experimental outcomes conditionally on the group labels, any number of data modalities may be combined in a single coherent probability model, allowing information sharing across experiment types. These two features result in parsimonious inference with few false positives, while simultaneously enhancing power to detect signals. Simulations show that our three-groups approach performs at least as well as commonly-used tools for GWAS and RNA-seq, and in some cases it performs better. We apply our proposed approach to publicly available genome-wide association studies and RNA-seq datasets, discovering novel genes that are potential therapeutic targets.

Indexed as

Genetic Predisposition to DiseaseModels, StatisticalParkinson DiseaseAlgorithmsComputer SimulationGenome-Wide Association StudyHumansModels, GeneticGWASnon-local priorRNA-seqvariable selection

Identifiers

PMID42216962
PMCPMC13221837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.